Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline <i>BRCA1</i> Mutation and High Tumor Mutation Burden: Case Report and Literature Review
Joanne Lundy, Owen McKay, Daniel Croagh, Vinod Ganju
Topics & Concepts
PembrolizumabMedicineMutationCancer researchGermlineGermline mutationOlaparibAdenocarcinomaInternal medicineOncologyMutation testingPancreatic ductal adenocarcinomaPancreatic cancerSomatic cellImmunotherapyPancreatic and Hepatic Oncology ResearchPARP inhibition in cancer therapyCancer Genomics and Diagnostics